Health knowledge and news provided by doctors.

Study Suggests Breast Cancer Is Caused By The Epstein Barr Virus

epstein barr virus herpes breast cancer

Epstein Barr Virus is an insidious herpetic virus with a reputation for lying-in-wait to strike.The virus works in a methodical and relentless manner over time systematically wrecking havoc on your body. Research into the complexities of the Epstein Barr Virus is exposing its prominent role in both autoimmune diseases and breast cancer, to name a few.


Breast Cancer Is The Most Common Disease Of Women

According to Global Cancer Statistics, breast cancer is the most commonly diagnosed cancer in women worldwide. About 1 in 8 U.S. women (about 12%) will develop invasive breast cancer over the course of her lifetime. While breast cancer being genetic remains to be questionable, more and more research links Epstein Barr Virus as the possible cause for the disease.

Related Article: This Is Why You Need To Get An Epstein Barr Test Now

Epstein Barr Virus Has A Long History

Epstein-Barr virus is an ancient virus, which has coevolved with many hosts over the last century. Many children acquire the infection in the first few years of life, but it isn’t often shown until adolescence or, not at all.

Epstein Barr Virus comes from the herpes family of viruses and often makes itself known when it is in its second stage – mononucleosis. However, not everyone with the Epstein Barr Virus gets mononucleosis, some may have a mild sore throat, or no symptoms at all, which is why knowing if you’ve got the Epstein Barr Virus is a bit tricky.

What makes Epstein Barr so insidious is that it has the ability to remain latent then intermittently reactivate after it’s primary infection, often with “mystery symptoms” label under autoimmune disease, that have puzzled the medical community for years.

Related Article: Is Removing Eggs From The Diet Key In Curing Type 2 Diabetes?

Epstein Barr Virus Prevalent In Patients With Breast Cancer

Epstein Barr Virus’s association with breast cancer and other cancers is nothing new, but the virus’ elusive nature makes it difficult to give conclusive results. That being said, a peer-reviewed study done on rural Indian Women with breast cancer and Epstein Barr Virus strongly suggests that Epstein Barr Virus may have a role in causing breast cancer.

The study looked for expression of Epstein-Barr Virus in breast cancer tissue specimens and also measured levels of antibodies in stored sera of these patients. Patients with benign breast diseases were used as a comparison group for analysis.

In the study, 58 cases of malignant breast disease and 63 of benign breast disease were included in the study. 90.9% cases and 81.8% controls were positive for Epstein Barr Virus.

Results showed that Epstein Barr Virus expression was seen in a significant proportion of breast cancer tissue specimens from rural India and as compared to patients with benign breast diseases. This may explain why so many women (and men) have developed the disease.

Follow eMaxHealth on YouTube, Twitter and Facebook.
Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.

Another peer-reviewed 2015 study published in the Journal PLoS One investigated cytomegalovirus and the Epstein Barr Virus in paired samples of breast cancer and normal breast tissue from 70 women. A serum sample was tested from both women for antibodies.

The age range of the women studied was 25–88, with most in the 40–54 year age-group. All the women had infiltrating ductal carcinoma, with 62% high-grade tumors. The vast majority of tissue samples (90.5%) were from women who had undergone mastectomy.

Epstein Barr Virus was detected in 24 (34%) of the 70 tumor specimens and in 9 (13%) of the paired normal specimens. Cytomegalovirus was detected in none of the tumor specimens and in 2 (3%) of the paired normal specimens.

Results showed that one or both viruses have a role at a later stage in breast cancer development; infection with multiple viruses increases breast cancer risk; or neither virus has a role, however future studies need to be done.

Related Article: 12 Foods That Reverse Type 2 Diabetes And Do Not Spike Blood Sugar

If You Have Or Had Breast Cancer, Get An Epstein Barr Test

Epstein Barr Virus also is associated with increased risk and development of several common autoimmune diseases. These include lupus, multiple sclerosis, thyroiditis, rheumatoid arthritis, inflammatory bowel diseases, insulin-dependent diabetes mellitus, Sjögren’s syndrome, systemic sclerosis, myasthenia gravis and autoimmune liver diseases (1-4). Getting an Epstein Barr test can will give you a better idea of root cause of the above disease, what you’re dealing with and how to proceed in your healing.

Information Is Power

Knowing the root cause of your symptoms can give you great relief, which aids in healing. If you have ever been dismissed after getting a positive result on an Epstein Barr blood test or told you ‘had’ the virus, but no longer have it, your practitioner is doing you a huge disservice.

Women as well as men need to know the root cause of their breast cancer and that Epstein Barr Virus can be managed by dealing with its various instigators in its early stages.

Although more research on the Epstein Barr Virus and its effects on the human body are needed, empower yourself by looking into whether or not you have the Epstein Barr Virus so you know what you’re dealing with. Should your test results be positive for antibodies to the virus, consider finding an Integrative or Functional practitioner or Naturopath who is willing to work with you on knocking back the Epstein Barr Virus naturally with diet and targeted supplementation. Addressing Epstein Barr Virus and its symptoms can prevent re-activation of the virus and can prevent further progression of disease.

Other Sources:

1. Bach F. Journal of Autoimmunity. 2005;25;supple-ment 74-80.
2. Barzilai O, et al. Current Opinion in Rheumatology. 2007;19(6):636-43.
3. Barzilai O, et al. Annals of the New York Academy of Sciences. 2007;1108:567-77.
4. Ercolini AM, et al. Clinical and Experimental Immunology. 2009;155(1):1-15.